TF, COPB2, IL‐18R1 in peripheral blood EVs, activated caspase‐3, and MLKL in platelet EVs exhibit strong correlations with the risk of microthrombosis, malignant disease progression, and hospital stay in patients with COVID‐19. The gene discussed is COPB2; the disease is COVID-19.